RPID vs PTHS
Comparison between Rapid Micro Biosystems Inc - Class A (RPID, Company) and Channel Therapeutics Corporation (PTHS, Company).
Both RPID and PTHS are from the Healthcare sector.
RPID vs PTHS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
RPID
$96M
Winner
PTHS
$96M
Max Drawdown
RPID
97.57%
Winner
PTHS
88.73%
Sharpe Ratio
RPID
-0.39
Winner
PTHS
0.81
5Y Beta
RPID
1.52
Winner
PTHS
1.08
Industry
RPID
Medical Devices
PTHS
Biotechnology
P/E Ratio
Winner
RPID
-1.93
PTHS
-0.73
PEG Ratio
RPID
0.00
Winner
PTHS
-0.00
Debt to Equity
RPID
93.41%
Winner
PTHS
0.00%
Free Cash Flow Yield
RPID
-39.62%
Winner
PTHS
-36.78%
P/S Ratio
Winner
RPID
3.06
PTHS
3.58
P/B Ratio
RPID
5.15
Winner
PTHS
2.84
RPID vs PTHS - Historical Returns
Returns include dividend reinvestment.
1M
RPID
-16.59%
Winner
PTHS
+9.23%
3M
RPID
-33.72%
Winner
PTHS
+8.01%
6M
RPID
-58.09%
Winner
PTHS
+28.86%
1Y
RPID
-47.55%
Winner
PTHS
+52.63%
5Y(CAGR)
RPID
-39.79%
PTHS
N/A
Max(CAGR)
RPID
-39.25%
Winner
PTHS
-18.38%
RPID vs PTHS - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | RPID | PTHS |
|---|---|---|
| 2026 | -45.54% | -1.53% |
| 2025 | +194.99% | +328.54% |
| 2024 | -0.78% | -86.65% |
| 2023 | -39.34% | N/A |
| 2022 | -89.57% | N/A |
| 2021 | -50.28% | N/A |
RPID vs PTHS Drawdown Comparison
The maximum drawdown for RPID was -97.57%, occurring on Jul 3, 2024. This drawdown has not yet recovered.
The maximum drawdown for PTHS was -88.73%, occurring on Nov 19, 2024. This drawdown has not yet recovered.
The current RPID drawdown is -93.10%. The current PTHS drawdown is -39.58%.
| Rank | RPID | PTHS |
|---|---|---|
| #1 | -97.57% Aug 5, 2021 - Jul 3, 2024 | -88.73% Feb 16, 2024 - Nov 19, 2024 |
| #2 | -17.01% Jul 16, 2021 - Aug 3, 2021 | N/A |
Correlation
Correlation between RPID and PTHS is 0.39 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.39
-101
Select Stocks to Compare
Popular: RPID vs SPYPTHS vs SPY
More Comparisons
Compare with similar stocks